375 related articles for article (PubMed ID: 31672303)
1. Treatment of Adrenocortical Carcinoma.
Vaidya A; Nehs M; Kilbridge K
Surg Pathol Clin; 2019 Dec; 12(4):997-1006. PubMed ID: 31672303
[TBL] [Abstract][Full Text] [Related]
2. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, treatment and outcome of adrenocortical cancer.
Mihai R
Br J Surg; 2015 Mar; 102(4):291-306. PubMed ID: 25689291
[TBL] [Abstract][Full Text] [Related]
4. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD
J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750
[TBL] [Abstract][Full Text] [Related]
6. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
[TBL] [Abstract][Full Text] [Related]
7. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?
Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X
J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.
Icard P; Goudet P; Charpenay C; Andreassian B; Carnaille B; Chapuis Y; Cougard P; Henry JF; Proye C
World J Surg; 2001 Jul; 25(7):891-7. PubMed ID: 11572030
[TBL] [Abstract][Full Text] [Related]
9. Contemporary management of adrenocortical carcinoma.
Zini L; Porpiglia F; Fassnacht M
Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
[TBL] [Abstract][Full Text] [Related]
10. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options.
Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1125-1133. PubMed ID: 30117750
[TBL] [Abstract][Full Text] [Related]
11. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical carcinoma.
Baudin E;
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging therapies for adrenocortical carcinoma--review.
Przytulska J; Rogala N; Bednarek-Tupikowska G
Adv Clin Exp Med; 2015; 24(2):185-93. PubMed ID: 25931348
[TBL] [Abstract][Full Text] [Related]
14. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
[TBL] [Abstract][Full Text] [Related]
15. Analysis of adjuvant chemotherapy in patients undergoing curative-intent resection of localized adrenocortical carcinoma.
Al Asadi A; Hubbs DM; Sweigert PJ; Baker MS; Kabaker AS
Am J Surg; 2021 Jul; 222(1):119-125. PubMed ID: 33168156
[TBL] [Abstract][Full Text] [Related]
16. Outcome of adrenocortical tumors in children.
Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
[TBL] [Abstract][Full Text] [Related]
17. A clinical study and treatment results of adrenocortical carcinoma patients presented in Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore.
Khan MS; Ali A; Tariq I; Khan MA; Bakar MA; Anwar AW
J Pak Med Assoc; 2019 May; 69(5):717-719. PubMed ID: 31105294
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical carcinoma: clinicopathological features, prognostic factors and outcome.
Keskin S; Taş F; Vatansever S
Urol Int; 2013; 90(4):435-8. PubMed ID: 23343838
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical Cancer Treatment.
Long SE; Miller BS
Surg Clin North Am; 2019 Aug; 99(4):759-771. PubMed ID: 31255205
[TBL] [Abstract][Full Text] [Related]
20. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
